These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27642050)

  • 1. Effects of NMDA receptor antagonists on probability discounting depend on the order of probability presentation.
    Yates JR; Breitenstein KA; Gunkel BT; Hughes MN; Johnson AB; Rogers KK; Shape SM
    Pharmacol Biochem Behav; 2016; 150-151():31-38. PubMed ID: 27642050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-methyl-D-aspartate receptor ligands on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting procedure.
    Yates JR; Gunkel BT; Rogers KK; Hughes MN; Prior NA
    Psychopharmacology (Berl); 2017 Feb; 234(3):461-473. PubMed ID: 27837332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GluN2B-selective antagonists on delay and probability discounting in male rats: Modulation by delay/probability presentation order.
    Yates JR; Prior NA; Chitwood MR; Day HA; Heidel JR; Hopkins SE; Muncie BT; Paradella-Bradley TA; Sestito AP; Vecchiola AN; Wells EE
    Exp Clin Psychopharmacol; 2018 Dec; 26(6):525-540. PubMed ID: 30035577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the NMDA receptor antagonists dizocilpine and Ro 63-1908 on delay-discounting and risky decision-making in a gambling task.
    Higgins GA; Silenieks LB; MacMillan C; Zeeb FD; Thevarkunnel S
    Behav Brain Res; 2018 Aug; 348():201-210. PubMed ID: 29689373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of N-methyl-d-aspartate receptor (NMDAr) uncompetitive antagonists in a delay discounting paradigm using a concurrent-chains procedure.
    Yates JR; Gunkel BT; Rogers KK; Breitenstein KA; Hughes MN; Johnson AB; Sharpe SM
    Behav Brain Res; 2018 Sep; 349():125-129. PubMed ID: 29604367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group I metabotropic glutamate receptor antagonists impair discriminability of reinforcer magnitude, but not risky choice, in a probability-discounting task.
    Yates JR; Chitwood MR; Evans KE; Kappesser JL; Murray CP; Paradella-Bradley TA; Torline BT
    Behav Brain Res; 2019 Jun; 365():77-81. PubMed ID: 30831139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of glutamate N-methyl-D-aspartate receptor antagonists on risky choice as assessed in the risky decision task.
    Yates JR; Horchar MJ; Ellis AL; Kappesser JL; Mbambu P; Sutphin TG; Dehner DS; Igwe HO; Wright MR
    Psychopharmacology (Berl); 2021 Jan; 238(1):133-148. PubMed ID: 32936321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intra-accumbal administration of dopamine and ionotropic glutamate receptor drugs on delay discounting performance in rats.
    Yates JR; Bardo MT
    Behav Neurosci; 2017 Oct; 131(5):392-405. PubMed ID: 28956947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Group I metabotropic glutamate receptor antagonists on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting task in rats: Contribution of delay presentation order.
    Yates JR; Rogers KK; Gunkel BT; Prior NA; Hughes MN; Sharpe SM; Campbell HL; Johnson AB; Keller MG; Breitenstein KA; Shults HN
    Behav Brain Res; 2017 Mar; 322(Pt A):29-33. PubMed ID: 28088471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pair housing, but not using a controlled reinforcer frequency procedure, attenuates the modulatory effect of probability presentation order on amphetamine-induced changes in risky choice.
    Yates JR; Ellis AL; Evans KE; Kappesser JL; Lilly KM; Mbambu P; Sutphin TG
    Behav Brain Res; 2020 Jul; 390():112669. PubMed ID: 32417278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ionotropic glutamate receptors in delay and probability discounting in the rat.
    Yates JR; Batten SR; Bardo MT; Beckmann JS
    Psychopharmacology (Berl); 2015 Apr; 232(7):1187-96. PubMed ID: 25270726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement.
    Allen RM; Carelli RM; Dykstra LA; Suchey TL; Everett CV
    J Pharmacol Exp Ther; 2005 Oct; 315(1):449-57. PubMed ID: 16024734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
    Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
    Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.
    Hillhouse TM; Porter JH
    Behav Pharmacol; 2014 Feb; 25(1):80-91. PubMed ID: 24370559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of d-amphetamine and MK-801 on impulsive choice: Modulation by schedule of reinforcement and delay length.
    Yates JR; Day HA; Evans KE; Igwe HO; Kappesser JL; Miller AL; Murray CP; Torline BT; Ellis AL; Stacy WL
    Behav Brain Res; 2019 Dec; 376():112228. PubMed ID: 31520689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
    Zhang XX; Bunney BS; Shi WX
    Synapse; 2000 Jul; 37(1):56-63. PubMed ID: 10842351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat.
    Ardayfio PA; Benvenga MJ; Chaney SF; Love PL; Catlow J; Swanson SP; Marek GJ
    J Pharmacol Exp Ther; 2008 Dec; 327(3):891-7. PubMed ID: 18772320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic and glutamatergic regulation of effort- and delay-based decision making.
    Floresco SB; Tse MT; Ghods-Sharifi S
    Neuropsychopharmacology; 2008 Jul; 33(8):1966-79. PubMed ID: 17805307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.